相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma
Ramona Erber et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Dynamic Immune/Inflammation Precision Medicine: The Good and the Bad Inflammation in Infection and Cancer
Jean-Francois Rossi et al.
FRONTIERS IN IMMUNOLOGY (2021)
The dual roles of A20 in cancer
Yongyu Shi et al.
CANCER LETTERS (2021)
Anti-PD-1 and Anti-PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
Andrea Botticelli et al.
FRONTIERS IN IMMUNOLOGY (2021)
Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities
Arne Martens et al.
NATURE IMMUNOLOGY (2020)
Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice
Chuang Xi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma
Gerrit Spanier et al.
ORAL ONCOLOGY (2020)
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma
Weinan Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A20: A multifunctional tool for regulating immunity and preventing disease
Barbara A. Malynn et al.
CELLULAR IMMUNOLOGY (2019)
Emerging role of zinc finger protein A20 as a suppressor of hepatocellular carcinoma
Peng Sheng Yi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
The potential role of TNFAIP3 in malignant transformation of gastric carcinoma
Bing Du et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
High A20 expression negatively impacts survival in patients with breast cancer
Chang Ik Yoon et al.
PLOS ONE (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy
Chuanzhen Yang et al.
CANCER RESEARCH (2018)
A20 Restrains Thymic Regulatory T Cell Development
Julius Clemens Fischer et al.
JOURNAL OF IMMUNOLOGY (2017)
A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1
Ji-Hyung Lee et al.
NATURE CELL BIOLOGY (2017)
A20 in inflammation and autoimmunity
Leen Catrysse et al.
TRENDS IN IMMUNOLOGY (2014)
NF-κB, an Active Player in Human Cancers
Yifeng Xia et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma
Prashant Bavi et al.
CLINICAL EPIGENETICS (2011)
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Noula Shembade et al.
SCIENCE (2010)
Constitutive activation of nuclear factor-kappa B is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines
Noritaka Yamaguchi et al.
CANCER SCIENCE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression
Xiao-Tong Song et al.
NATURE MEDICINE (2008)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
NF-kB in development and progression of human cancer
X Dolcet et al.
VIRCHOWS ARCHIV (2005)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Infections as a major preventable cause of human cancer
H Kuper et al.
JOURNAL OF INTERNAL MEDICINE (2000)
分享论文
